Results from ongoing study suggest the major role of Celartics' Cov-DCVax in preventing viral infection of COVID-19 and in controlling progression of the virus-associated diseasesBeijing, May 22, 2020, Celartics Biopharma announced today the filing of a patent application covering a novel dendritic cell (DC)-based vaccine, Cov-DCVax, to fight viral infection of COVID-19. The results, led by Celart
不斷更新/明日停班停課資訊 嘉義縣宣布了
08-01
快訊/3地區「明天雨量」達停班課標準
08-01
淑麗氣象/中南部大豪雨狂炸!雨停時間曝光
08-01
夫妻雙薪6.8萬 卻存不到錢!網友看開銷搖頭了
08-01